Menlo Park, CA
Allocation by class
Portfolio Concentration
Top 3 weight
33.7%
Top 10 weight
58.8%
Voting Authority Distribution
Total shares with voting rights: 42.39M
Full voting authority
42.39M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Natera IncSOLE | COM | 1.55M | SH | $420.82M 21.76% | 1.55M | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 2.79M | SH | $119.89M 6.20% | 2.79M | 0.00 | 0.00 |
Genmab A/SSOLE | SPONSORED ADS | 4.05M | SH | $111.12M 5.74% | 4.05M | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 365.34K | SH | $88.04M 4.55% | 365.34K | 0.00 | 0.00 |
Rapport Therapeutics IncSOLE | COM | 1.90M | SH | $79.36M 4.10% | 1.90M | 0.00 | 0.00 |
Seaport Therapeutics IncSOLE | COM | 3.56M | SH | $77.43M 4.00% | 3.56M | 0.00 | 0.00 |
Ultragenyx Pharmaceutical InSOLE | COM | 2.22M | SH | $74.04M 3.83% | 2.22M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | COM | 1.70M | SH | $58.95M 3.05% | 1.70M | 0.00 | 0.00 |
BioAge Labs IncSOLE | COM | 2.29M | SH | $56.22M 2.91% | 2.29M | 0.00 | 0.00 |
Bristol-Myers Squibb CoSOLE | COM | 876.97K | SH | $50.53M 2.61% | 876.97K | 0.00 | 0.00 |
Supernus PharmaceuticalsSOLE | COM | 1.04M | SH | $48.20M 2.49% | 1.04M | 0.00 | 0.00 |
Rhythm Pharmaceuticals IncSOLE | COM | 408.03K | SH | $45.30M 2.34% | 408.03K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 343.10K | SH | $43.35M 2.24% | 343.10K | 0.00 | 0.00 |
United Therapeutics Corp DelSOLE | COM | 76.49K | SH | $41.44M 2.14% | 76.49K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | COM | 1.04M | SH | $40.06M 2.07% | 1.04M | 0.00 | 0.00 |
Axsome Therapeutics Inc.SOLE | COM | 160.43K | SH | $39.27M 2.03% | 160.43K | 0.00 | 0.00 |
Immatics N.VSOLE | SHS | 3.67M | SH | $37.17M 1.92% | 3.67M | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | COM | 1.66M | SH | $36.83M 1.90% | 1.66M | 0.00 | 0.00 |
Immunome IncSOLE | COM | 1.72M | SH | $36.45M 1.88% | 1.72M | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 925.12K | SH | $34.48M 1.78% | 925.12K | 0.00 | 0.00 |
Anaptysbio IncSOLE | COM | 493.54K | SH | $33.31M 1.72% | 493.54K | 0.00 | 0.00 |
Nektar TherapeuticsSOLE | COM NEW | 471.76K | SH | $32.93M 1.70% | 471.76K | 0.00 | 0.00 |
Pharvaris N VSOLE | COM | 881.30K | SH | $30.48M 1.58% | 881.30K | 0.00 | 0.00 |
Arcus Biosciences IncSOLE | COM | 945.69K | SH | $29.16M 1.51% | 945.69K | 0.00 | 0.00 |
Inhibrx Biosciences IncSOLE | COM | 303.10K | SH | $28.72M 1.48% | 303.10K | 0.00 | 0.00 |